These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Vrabec TR; Baldassano VF; Whitcup SM Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231 [TBL] [Abstract][Full Text] [Related]
5. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy. Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C; AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865 [TBL] [Abstract][Full Text] [Related]
6. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789 [TBL] [Abstract][Full Text] [Related]
7. Withdrawal of maintenance therapy for cytomegalovirus retinitis in AIDS patients exhibiting immunological response to HAART. Waib LF; Bonon SH; Salles AC; Benard G; de Oliveira AC; Pannuti CS; Pedro Rde J; Costa SC Rev Inst Med Trop Sao Paulo; 2007; 49(4):215-9. PubMed ID: 17823749 [TBL] [Abstract][Full Text] [Related]
8. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. Macdonald JC; Torriani FJ; Morse LS; Karavellas MP; Reed JB; Freeman WR J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001 [TBL] [Abstract][Full Text] [Related]
9. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. Wohl DA; Kendall MA; Owens S; Holland G; Nokta M; Spector SA; Schrier R; Fiscus S; Davis M; Jacobson MA; Currier JS; Squires K; Alston-Smith B; Andersen J; Freeman WR; Higgins M; Torriani FJ; HIV Clin Trials; 2005; 6(3):136-46. PubMed ID: 16192248 [TBL] [Abstract][Full Text] [Related]
10. Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis. Jacobson MA; Maecker HT; Orr PL; D'Amico R; Van Natta M; Li XD; Pollard RB; Bredt BM; J Infect Dis; 2004 Apr; 189(8):1362-73. PubMed ID: 15073672 [TBL] [Abstract][Full Text] [Related]
11. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis. Macdonald JC; Karavellas MP; Torriani FJ; Morse LS; Smith IL; Reed JB; Freeman WR Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078 [TBL] [Abstract][Full Text] [Related]
12. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. Tural C; Romeu J; Sirera G; Andreu D; Conejero M; Ruiz S; Jou A; Bonjoch A; Ruiz L; Arnó A; Clotet B J Infect Dis; 1998 Apr; 177(4):1080-3. PubMed ID: 9534987 [TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study. Mitchell SM; Membrey WL; Youle MS; Obi A; Worrell S; Gazzard BG Br J Ophthalmol; 1999 Jun; 83(6):652-5. PubMed ID: 10340970 [TBL] [Abstract][Full Text] [Related]
14. Effect of combination antiretroviral therapy on cytomegalovirus retinitis. Banker AS; Patel A Indian J Ophthalmol; 2002 Mar; 50(1):29-33. PubMed ID: 12090084 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Kedhar SR; Jabs DA Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289 [TBL] [Abstract][Full Text] [Related]
16. CMVR diagnoses and progression of CD4 cell counts and HIV viral load measurements in HIV patients on HAART. Zambarakji HJ; Newson RB; Mitchell SM Br J Ophthalmol; 2001 Jul; 85(7):837-41. PubMed ID: 11423459 [TBL] [Abstract][Full Text] [Related]
17. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution. Johnson SC; Benson CA; Johnson DW; Weinberg A Clin Infect Dis; 2001 Mar; 32(5):815-9. PubMed ID: 11229851 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD; Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751 [TBL] [Abstract][Full Text] [Related]
19. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Tufail A; Moe AA; Miller MJ; Wagar EA; Bruckner DA; Holland GN Ophthalmology; 1999 Jan; 106(1):133-41. PubMed ID: 9917794 [TBL] [Abstract][Full Text] [Related]
20. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series. Reed JB; Briggs JW; McDonald JC; Freeman WR; Morse LS Retina; 2001; 21(4):339-43. PubMed ID: 11508879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]